Close Menu

NEW YORK – Geneoscopy announced today that it has raised $6.9 million in a Series A financing round. 

The St. Louis-based startup will use the funding to develop its colorectal cancer (CRC) screening assay, which measures eukaryotic RNA isolated from epithelial cells in stool to diagnose CRC and advanced adenomas. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.